BioSpace News Archive

SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, today announced successful results from a pre-clinical trial performed by Professor Joseph Tam from The Hebrew University of Jerusalem.

Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, proudly announces the presentation of its novel precision vaccine concept at the 65th American Society of Hematology (ASH) Annual Meeting, taking place in San Diego, California, from December 9-12, 2023.

Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced it has entered into an agreement with Bioline Supply to distribute the CompuFlo® Epidural System and related disposables in Spain.

Ainos, Inc. today announced that its contract manufacturer, Swiss Pharmaceutical Co., Ltd. (Taiwan) (“Swiss Pharma”), has completed manufacturing of a Good Manufacturing Practice (“GMP”) Clinical Batch of the Company’s VELDONA® investigational new drugs.

Stereotaxis and Baptist Health Lexington announced that physicians have built upon their two-decades of leadership in robotic heart care with the successful treatment of first patients using the newest advancement in the technology, the Genesis Robotic Magnetic Navigation System.

Hurdle, a pioneer in diagnostic testing, and the Consumer Health division of Bayer have launched a strategic partnership to advance consumer innovations in the emerging area of healthy aging.

Committed to supporting research vital to the field of spinal care, DISC Surgery Center at Newport Beach (“DISC”) has announced its participation in a clinical study on artificial disc replacement and is now enrolling qualified patients.

RoyalPhilips, a global leader in health technology, launched three new fit for purpose MR Smart Fit coils at #RSNA23.

VIVUS LLC announced positive topline data from a post-marketing study to evaluate the effect of QSYMIA® on 24-hour ambulatory blood pressure .

180 Life Sciences Corp., announced that its Board of Directors has initiated a process to evaluate potential strategic alternatives with the intent to unlock and maximize shareholder value.